Akili Inc Stock Cash And Equivalents
AKLIDelisted Stock | USD 0.43 0.00 0.00% |
Akili Inc fundamentals help investors to digest information that contributes to Akili's financial success or failures. It also enables traders to predict the movement of Akili Stock. The fundamental analysis module provides a way to measure Akili's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akili stock.
Akili |
Akili Inc Company Cash And Equivalents Analysis
Akili's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Akili Cash And Equivalents | 45.62 M |
Most of Akili's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akili Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Akili Inc has 45.62 M in Cash And Equivalents. This is 94.44% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 98.31% higher than that of the company.
Akili Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akili's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akili could also be used in its relative valuation, which is a method of valuing Akili by comparing valuation metrics of similar companies.Akili is currently under evaluation in cash and equivalents category among its peers.
Akili Fundamentals
Return On Equity | -0.68 | |||
Return On Asset | -0.37 | |||
Operating Margin | (28.37) % | |||
Current Valuation | (15.56 M) | |||
Shares Outstanding | 78.73 M | |||
Shares Owned By Insiders | 23.21 % | |||
Shares Owned By Institutions | 61.47 % | |||
Number Of Shares Shorted | 271.35 K | |||
Price To Book | 0.35 X | |||
Price To Sales | 12.31 X | |||
Revenue | 1.68 M | |||
Gross Profit | (118 K) | |||
EBITDA | (60.14 M) | |||
Net Income | (59.49 M) | |||
Cash And Equivalents | 45.62 M | |||
Cash Per Share | 0.53 X | |||
Total Debt | 15.48 M | |||
Debt To Equity | 0.79 % | |||
Current Ratio | 4.78 X | |||
Book Value Per Share | 0.64 X | |||
Cash Flow From Operations | (57.87 M) | |||
Short Ratio | 0.31 X | |||
Earnings Per Share | (0.61) X | |||
Target Price | 0.65 | |||
Number Of Employees | 68 | |||
Beta | 1.73 | |||
Market Capitalization | 34.1 M | |||
Total Asset | 80.38 M | |||
Retained Earnings | (299.78 M) | |||
Working Capital | 65.06 M | |||
Net Asset | 80.38 M |
About Akili Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akili Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akili using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akili Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Akili Stock
If you are still planning to invest in Akili Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akili's history and understand the potential risks before investing.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Fundamental Analysis View fundamental data based on most recent published financial statements |